Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(S,R,S)-AHPC-PEG6-C4-Cl

Copy Product Info
😃Good
Catalog No. T17926Cas No. 1835705-59-3
Alias VHL Ligand-Linker Conjugates 10, VH032-PEG6-C4-Cl, E3 ligase Ligand-Linker Conjugates 9

(S,R,S)-AHPC-PEG6-C4-Cl is a small molecule HaloPROTAC comprising the (S,R,S)-AHPC based VHL ligand and a 6-unit PEG linker, capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1].

(S,R,S)-AHPC-PEG6-C4-Cl

(S,R,S)-AHPC-PEG6-C4-Cl

Copy Product Info
😃Good
Catalog No. T17926Alias VHL Ligand-Linker Conjugates 10, VH032-PEG6-C4-Cl, E3 ligase Ligand-Linker Conjugates 9Cas No. 1835705-59-3
(S,R,S)-AHPC-PEG6-C4-Cl is a small molecule HaloPROTAC comprising the (S,R,S)-AHPC based VHL ligand and a 6-unit PEG linker, capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$615 days5 days
5 mg$98InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
(S,R,S)-AHPC-PEG6-C4-Cl is a small molecule HaloPROTAC comprising the (S,R,S)-AHPC based VHL ligand and a 6-unit PEG linker, capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1].
In vitro
HaloPROTACs are engineered to facilitate the ubiquitylation and subsequent degradation of HaloTag7 fusion proteins[1].
SynonymsVHL Ligand-Linker Conjugates 10, VH032-PEG6-C4-Cl, E3 ligase Ligand-Linker Conjugates 9
Chemical Properties
Molecular Weight827.47
FormulaC40H63ClN4O10S
Cas No.1835705-59-3
SmilesC([C@@H](NC(COCCOCCOCCOCCOCCOCCCCCCCl)=O)[C@@](C)(C)C)(=O)N1[C@H](C(NCC2=CC=C(C=C2)C=3SC=NC3C)=O)C[C@@H](O)C1
Relative Density.1.195 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (120.85 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (3.99 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2085 mL6.0425 mL12.0850 mL60.4252 mL
5 mM0.2417 mL1.2085 mL2.4170 mL12.0850 mL
10 mM0.1209 mL0.6043 mL1.2085 mL6.0425 mL
20 mM0.0604 mL0.3021 mL0.6043 mL3.0213 mL
50 mM0.0242 mL0.1209 mL0.2417 mL1.2085 mL
100 mM0.0121 mL0.0604 mL0.1209 mL0.6043 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (S,R,S)-AHPC-PEG6-C4-Cl | purchase (S,R,S)-AHPC-PEG6-C4-Cl | (S,R,S)-AHPC-PEG6-C4-Cl cost | order (S,R,S)-AHPC-PEG6-C4-Cl | (S,R,S)-AHPC-PEG6-C4-Cl chemical structure | (S,R,S)-AHPC-PEG6-C4-Cl in vitro | (S,R,S)-AHPC-PEG6-C4-Cl formula | (S,R,S)-AHPC-PEG6-C4-Cl molecular weight